Renal vasoconstrictor response to 5-hydroxytryptamine in the in situ autoperfused rat kidney: Involvement of angiotensin II and the 5-HT2 receptor activation

European Journal of Pharmacology

Volumn 330, Issue 2-3, 1997, Pages 205-211

  Morán, Asunción ^a   Velasco, Cristina ^a   Martín, Maria Luisa ^a   San Román, Luis ^a  

^a Depto Fisiol y Farmacologia   (Spain)

Author keywords

5 HT (5 hydroxytryptamine, serotonin); 5 HT receptor agonists; Angiotensin II; Autoperfused; Kidney; Rat; Renal blood flow

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 1 (3 CHLOROPHENYL)BIGUANIDE; 5 CARBAMOYLTRYPTAMINE; ANGIOTENSIN; ENALAPRIL; INDOMETACIN; LOSARTAN; PRAZOSIN; PROPRANOLOL; RITANSERIN; SEROTONIN; SEROTONIN 2 RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOSE KIDNEY FUNCTION RELATION; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ELECTRIC STIMULATION; KIDNEY; MALE; PERFUSION; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0030832518     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01006-6     Document Type: Article

References (31)

1. 2 receptor agonist, in conscious rats. Eur. J. Pharmacol. 175:1990;232-332.
2. Alper R.H., Ganong W.F. Pharmacological evidence that the sympathetic nervous system mediates the increase in secretion of renin produced by p-chloroamphetamine. Neuropharmacology. 23:1984;1237-1240.
3. 2) receptors by quipazine increases arterial pressure and renin secretion in conscious rat. J. Pharmacol. Exp. Ther. 243:1987;829-833.
4. 2-antagonist. Drug. Dev. Res. 15:1988;61-73.
5. Blackshear J.L., Orlandi C., Hollenberg N.K. Constrictive effect of serotonin on visible renal arteries: A pharmacoangiographic study in anaesthetized dogs. J. Cardiovasc. Pharmacol. 17:1991;67-73.
6. 2 receptor. Kidney Int. 30:1986;304-310.
7. 1-adrenoceptors. Naunyn-Schmiedebergs Arch. Pharmacol. 328:1984;154-157.
8. Ding X.R., Stier C.T., Itskovitz H.D. Serotonin and 5-hydroxytryptophan on blood pressure and renal blood flow in anaesthetized rats. Am. J. Med. Sci. 297:1989;290-293.
9. Dupont A.G., Lefebvre R.A., Bogaert M.G. Inhibition of noradrenergic neurotransmission by apomorphine and pergolide in the in situ autoperfused renal and superior mesenteric vascular beds. Naunyn-Schmiedebergs Arch. Pharmacol. 333:1986;229-234.
10. Endlich K., Kühn R., Steinhausen M., Dussel R. Visualization of serotonin effects on renal vessels of rats. Kidney Int. 43:1993;314-323.
11. Fink G.D., Brody M.J. Continuous measurement of renal blood flow changes to renal nerve stimulation and intra-arterial drug administration in rat. Am. J. Physiol. 234:1978;H219-H222.
12. Gerber J.G., Nies A.S., Olsen R.D. Control of canine renin release: Macula densa requires prostaglandin synthesis. J. Physiol. 318:1981;419-429.
13. Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R., Mylecharane E.J., Saxena P.R., Humphrey P.P.A. VII. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46:1994;157-203.
14. Humphrey P.P.A., Hartig P., Hoyer D. A proposed new nomenclature for 5-HT receptors. Trends Pharmacol. Sci. 14:1993;233-236.
15. 1-adrenoceptor antagonist, in anaesthetized rabbits. J. Cardiovasc. Pharmacol. 10:1987;S69-S72.
16. Janssen W.J., Van Nueten J.M. The direct and amplifying effects of serotonin are increased with age in the isolated perfused kidney of wistar and spontaneously hypertensive rats. Naunyn-Schmiedebergs Arch. Pharmacol. 334:1986;327-332.
17. Lamiere N.H., Matthys E., Kesteloot D., Waterloos M.A. Effect of a serotonin blocking agent on renal hemodynamics in the normal rat. Kidney Int. 38:1990;823-829.
18. 2) agonists and antagonists on renin and corticosteroid secretion. Neuroendocrinology. 45:1987;305-310.
19. Roman R.J., Kauker M.L. Renal effect of prostaglandin synthetase inhibition in rats: Micropuncture studies. Am. J. Physiol. 235:1978;F111-F118.
20. Roquebert J., Moran A., Demichel P. Effect of quinpirole on neurogenic vasoconstriction in the in situ autoperfused hindquarters and renal vascular beds of the rat. J. Auton. Pharmacol. 12:1992;291-298.
21. Shoji T., Tamaki T., Fukui K., Iwao H., Abe Y. Renal hemodynamic responses to 5-hydroxytryptamine (5-HT): Involvement of the 5-HT receptor subtypes in the canine kidney. Eur. J. Pharmacol. 171:1989;219-228.
22. Stier C.T. Jr., Mckendall G., Itskovitz H.D. Serotonin formation in nonblood-perfused rat kidneys. J. Pharmacol. Exp. Ther. 228:1984;53-56.
23. Stier C.T. Jr., Brewer T.F., Dick L.B., Wynn N., Itskovitz H.D. Formation of biogenic amines by isolated kidneys of spontaneously hypertensive rats. Life Sci. 38:1986;7-14.
24. Tadipatri S., Van Heuven-Nolsen D., Feniuk W., Saxena P.R. Analysis of the 5-HT receptors mediating contractions in the rabbit isolated renal artery. Br. J. Pharmacol. 104:1991;887-894.
25. Takahashi T., Hisa H., Satoh S. Serotonin-induced renin release in the dog kidney. Eur. J. Pharmacol. 193:1991;315-320.
26. Tuncer M., Vanhoutte P.M. Role of prostanoids in the increased vascular responsiveness and delayed tachyphylaxis to serotonin in the kidney of spontaneously hypertensive rats. J. Hypertens. 9:1991;623-629.
27. Van De Kar L.D., Wilkinson C.W., Ganong W.F. Pharmacological evidence for a role of brain serotonin in the maintenance of plasma renin activity in unanesthetized rats. J. Pharmacol. Exp. Ther. 219:1981;85-90.
28. 1A receptors involved? Eur. J. Pharmacol. 201:1991;17-27.
29. Wright C.E., Angus J.A. Diverse vascular responses to serotonin in the conscious rabbit: Effects of serotonin antagonists on renal artery spasm. J. Cardiovasc. Pharmacol. 10:1987;415-421.
30. Zimmermann H., Ganong W.F. Pharmacological evidence that stimulation of central serotonergic pathways increases renin secretion. Neuroendocrinology. 30:1980;101-107.
31. Zink M.H., Pergola P.E., Doane J.F., Sved A.F., Alper R.H. Quipazine increases renin release by a peripheral hemodynamic mechanism. J. Cardiovasc. Pharmacol. 15:1990;1-9.